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Abstract  
Myxoma virus (MYXV), a member of the Poxviridae family, is the agent 
responsible for myxomatosis, a fatal disease in the European rabbit (Oryctolagus
cuniculus). MYXV has a linear double-stranded DNA genome that encodes 
several factors important for evasion from the host immune system. Among them, 
four ankyrin (ANK) repeat proteins were identified: M148R, M149R, M150R and 
M-T5. To date, only M150R and M-T5 were studied and characterized as critical 
virulence factors. This article presents the first characterization of M148R and 
M149R. GFP fusions allowed us to localize them in a viral context. Whereas 
M149R is only cytoplasmic, interestingly, M148R is in part located in the 
nucleolus, a unique feature for an ANK repeat poxviral protein. In order to 
evaluate their implication in viral pathogenicity, targeted M148R, M149R, or both 
deletions were constructed in the wild type T1 strain of myxoma virus. In vitro 
infection of rabbit and primate cultured cells as well as primary rabbit cells 
allowed us to conclude that M148R and M149R are not likely to be implicated in 
cell tropism or host range functions. However, in vivo experiments revealed that 
they are virulence factors since after infection of European rabbits with mutant 
viruses, a delay in the onset of clinical signs, an increase of survival time and a 
dramatic decrease in mortality rate were observed. Moreover, histological analysis 
suggests that M148R plays a role in the subversion of host inflammatory response 
by MYXV. 
 
Keywords: poxvirus / myxoma virus /  ankyrin repeat / virulence / rabbit 
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1. Introduction 
Myxoma virus (MYXV), a member of the Poxviridae family, is the agent 
responsible for myxomatosis, a highly lethal disease in the European rabbit 
(Oryctolagus cuniculus). The main anatomical and clinical features of 
myxomatosis are a pseudotumoral lesion at the inoculation site followed by the 
occurrence of secondary lesions at cutaneous and visceral levels, named myxomas 
[29]. Due to MYXV's particular ability to escape and subvert the host artillery, 
these lesions are accompanied by general dysfunction of cellular immunity, 
resulting in bacterial super infections of the respiratory tract culminating in death 
within 2 weeks [29]. 
MYXV has a double-stranded DNA genome of 162 kbp [5], with a central region 
containing highly conserved enzymatic and structural genes required for the 
maintenance of essential viral functions. Peripheral regions of the DNA, within 
and near the inverted terminal repeats (ITR) at both sides of the genome, encode 
nonessential factors that contribute to the modulation of the host response to 
infection [29, 32, 31]. Two genes present near the right ITR, M148R and M149R, 
have functions that are still speculative. They encode two of the four ankyrin 
(ANK) repeat-containing proteins of the MYXV [5, 17]. The ANK repeat is one 
of the most common, modular, protein-protein interaction motifs in nature. This 
module is involved in a wide range of cellular functions. The importance of the 
MYXV-ANK-repeat proteins has been demonstrated: MT-5 is a host-range factor 
essential for permissive MYXV infection in rabbit lymphocytes [18, 34], and 
MNF seems to interfere with NFKB pathways, leading to the inhibition of 
inflammatory response [6]. Disruption of either one of these genes results in 
dramatic attenuation of myxomatosis in infected European rabbits. Interestingly, 
M148R, M149R, and MNF (M150R) are located in series on the MYXV genome, 
forming a cluster of ANK repeats encoding genes at the right end of the MYXV 
genome. 
Here we present the first characterization of M148R and M149R. Our data 
suggest that they are both virulence factors of MYXV, with different cellular 
localizations and acting in different ways compared to the other ANK repeat 
MYXV proteins. 
 
2. Materials and Methods 
2.1. Cells and viruses 
Rabbit kidney cells (RK13; ATCC CCL-37), RK13 HGPRT- cells (deficient in 
hypoxanthine-guanine phosphoribosyl transferase) and Baby Green Monkey 
Kidney cells (BGMK) were maintained in Dulbecco minimum essential medium 
(DMEM) supplemented with 10% fetal calf serum (FCS). Rabbit peripheral blood 
mononuclear cells (PBMC) were isolated and cultured as previously described 
[23].The wild type MYXV strain T1 and the MYXV mutants (MYXV-M148R, 
MYXV-M149R and MYXV-M148RM149R) were grown in RK13 cells, in 
DMEM supplemented with 5% FCS. 
 
2.2. Cloning, sequencing and computer analysis of DNA and protein 
sequences 
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DNA sequences were analyzed with DNA Strider 1.3 software [15] and the 
BLAST program [35]. Searches for ANK repeats were performed with REP1 [1]; 
Pfam2 [11]; and SMART3 [14]; online software packages. Manual analysis, 
according to published consensus promoter sequences [4], was performed to 
predict M148R and M149R expression during the infection cycle. 
 
2.3. RNA extraction and RT-PCR analysis 
RK13 cells (2 × 106 cells) were infected with wild type MYXV strain T1 at a 
multiplicity of infection (m.o.i.) of 5. The inoculum was allowed to adsorb for 1 
hour at 4 °C. Total RNA was isolated at 0, 2, 4, 8, 12 and 16 h post-infection (p.i.) 
(NucleoSpin RNA II; Macherey-Nagel, Hoerd, France). In addition, total RNA 
was also extracted at 16 h p.i. from mock infected cells and from T1 infected cells 
treated with 40 μg/mL cytosine arabinoside (AraC) (SIGMA, Lyon, France) at the 
time of infection. All RNA samples were subjected to DNaseI treatment. Reverse 
transcription was performed using oligo-dT and M-MLV reverse transcriptase 
(Invitrogen, Paisley, UK), and followed by PCR analysis using specific primers of 
M148R (5'M148R-BglII (5'-
CGAAGATCTATGGATCACGTAAGCTATTACATTGT-3') and 3’M148R-PstI 
(5'-AAACTGCAGGTAAACCGAACGTATCTATGCAAC-3')) or M149R 
(5'M149R-BamHI (5'-CGCGGATCCGCAATTATGGCCTCGTTGCAT-3') and 
3'M149R-PstI (5'-AAACTGCAGCGCACTATTTTGTACGGTTTA-3') 
(restriction sites are underlined). PCR (Expand High Fidelity; Roche, Basel, 
Switzerland) were performed over 30 cycles, with a hybridization temperature of 
63 °C for each cycle. A control RT-PCR, in which reverse transcriptase was 
omitted during the RT step, was performed with all samples (not shown). 
 
2.4. Engineering of GFP fusions 
GFP fusions, under CMV promoter, were obtained using the pEGFP-F plasmid 
vector (BD Biosciences-Clontech, Saint-Germain-en-Laye, France). The M148R 
open reading frame was amplified by PCR using 5'M148RBglII and 
3’M148RPstI. The M149R open reading frame was amplified by PCR using 
5'M149RBamHI and 3'M149RPstI. The resulting PCR fragments were inserted 
between the BglII and PstI sites in pEGFP-F, thus replacing the farsenylation box-
coding sequence downstream of the GFP sequence. The resulting plasmids have 
been named pCMV-GFPM148R and pCMV-GFPM149R. 
The P7.5 early/late poxviral promoter, issued from pSC11 [7], was digested by 
XbaI-BamHI and cloned into pBluescript-SK (Stratagene, Massy, France). The 
resulting plasmid pBS-P7.5 was digested by XmaI and KpnI to insert, under P7.5 
poxviral promoter, the entire GFP fusion sequence of M148R or M149R, 
provided by AgeI-KpnI digestion of pCMV-GFPM148R and pCMV-GFPM149R, 
respectively. The resulting plasmids are pBS-P7.5GFPM148R and pBS-
P7.5GFPM149R, respectively. 
 
                                                 
1 http://www.embl-heidelberg.de/~andrade/papers/rep/search.html 
2 http://pfam.sanger.ac.uk/search 
3 http://smart.embl-heidelberg.de/ 
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2.5. Confocal microscopy observations 
BGMK cells were plated onto multichamber slide flasks (Falcon, Le Pont de 
Claix, France), transfected with plasmid expressing GFP fusion of M148R or 
M149R under P7.5 or CMV promoter, with or without prior infection for 2 h with 
MYXV deleted for the corresponding gene. Twenty-four hour post-transfection 
(p.t.), cells were fixed with 4% paraformaldehyde in PBS and permeabilized with 
0.1% Triton X-100. Cells were incubated with mouse anti-human B23 antibodies 
(1/100; SIGMA) or anti-MYXV serum (1/500) in 0.05% Tween in PBS and then 
with rhodamine RX coupled anti-mouse antibodies (1/200; Jackson 
Immunoresearch, West Grove, PA, USA) or CY-5 coupled anti-rabbit antibodies 
(1/200; Immunotech, Villepinte, France), respectively. Some samples were 
stained with TO-PRO-3 iodide (Invitrogen). Samples were observed with a 
confocal LSM Olympus microscope. Multistaining experiments were performed 
using the sequential mode. 
 
2.6. Construction of MYXV-M148R, MYXV-M149R, MYXV-
M148RM149R, and revertant viruses 
Briefly, inactivation of the target open reading frames (M148R, M149R or both) 
was achieved by homologous recombination in MYXV infected RK13 cells, 
transfected with the appropriate plasmid. The M149R gene, amplified by PCR 
(using 5'M149RBamHI and 3'M149RPstI primers) and cloned into the pGEM-T 
vector (Promega, Charbonnieres, France) was inactivated by replacing the SnaBI-
BglII central region (785 bp) by the LacZ gene, under the control of the late 
Vaccinia virus promoter P11, issued from pSC11 [7]. After homologous 
recombination in MYXV T1 infected cells, MYXV-M149R mutant was 
screened for blue plaque in the presence of X-Gal (5-bromo-4-chloro-3-indolyl--
D-galactopyranoside).  
M148R gene, amplified by PCR (using 5'M148RBglII and 3’M148RPstI ) and 
cloned into the pGEM-T expression vector (Promega), was inactivated by 
replacing the SnaBI-EcoRV central region (1051 bp) by the Ecogpt gene 
(Escherichia coli xanthine-guanine phosphoribosyl transferase), under the control 
of the P7.5 promoter issued from the digest of pRBgpt [9]. After recombination in 
MYXV infected RK13 cells, MYXV-M148R mutants were selected by 
resistance to mycophenolic acid in DMEM supplemented with 25 μg/mL 
mycophenolic acid (MPA), 250 μg/mL xanthine and HAT (Hypoxanthine 
Aminopterin Thymidine; SIGMA, 1/50).  
The MYXV-M148RM149R was obtained by transfecting MYXV-M149R 
infected RK13 cells with the plasmid containing the inactivated form of M148R. 
MYXV-M148RM149R was selected by resistance to mycophenolic acid. 
Purity of all mutant viruses was verified by PCR. 
In order to engineer a revertant virus (MYXV-rev), the native sequence including 
M148R and M149R open reading frames was obtained by PCR using 
5'M148RBglII and 3'M149RPstI primers, and cloned into pGEM-T. After 
recombination in MYXV-M148RM149R-infected RK13 HGPRT- cells, 
MYXV-rev was obtained by reverse Ecogpt selection using 6-thioguanine (5 
μg/mL) and by reverse white-blue screening. 
 6
 
2.7. Infection and virus growth curves 
For growth analysis in rabbit PBMC, 6 × 106 cells were infected with T1, MYXV-
M148R, MYXV-M149R or MYXV-M148RM149R at an m.o.i. of 1. For 
single-step analysis on RK13 and BGMK, 5 × 105 cells were infected with wild 
type MYXV or mutant viruses at an m.o.i. of 4. For Multi-step analysis on RK13 
and BGMK, 5 × 105 cells were infected with viruses at an m.o.i. of 0.01. 
The inoculums were allowed to adsorb for 2 h at 4 °C. Then, unabsorbed viruses 
were removed, and cells were incubated in DMEM supplemented with 5% FCS. 
At different times p.i., cells were scraped, frozen and virus titers were determined 
on RK13 cells. 
 
2.8. Infection of rabbits with wild-type MYXV, MYXV-rev, MYXV-M148R, 
MYXV-M149R and MYXV-M148RM149R  
Eight-week old male New Zealand White rabbits were obtained from a local 
supplier and housed in biocontainment facilities according to the guidelines of the 
European Community Council on Animal Care (European Council directive 
86/609/EEC, 24 November 1986). All procedures on animals were performed by 
staff accredited by the French Ministry of Agriculture and were designed to limit 
animal pain and distress. Infections were performed intradermally in the right ear 
with 5 × 103 PFU of either virus. Rabbits were monitored daily for clinical signs 
of myxomatosis. Rabbits that became moribund were sacrificed with T61 
(Distrivet, Romainville, France) administered intravenously. 
 
2.9. Histological examination 
For histological studies, six rabbits were inoculated with MYXV strain T1 and six 
were inoculated with each mutant-virus described above. At 5, 8, and 13 days p.i., 
two animals from each group were sacrificed. Two mock-infected rabbits were 
sacrificed and used as controls. All animals were subjected to complete post-
mortem examination. Tissue material from the injection site (ear [primary site]) 
and parotid lymph node (secondary site) were taken and stored in 10% neutral 
formalin for further analysis. After fixation, tissues were routinely processed into 
paraffin blocks, sectioned at a thickness of 4 μm, and stained with haematoxylin 
and eosin for microscopic examination. Lesions were assessed histologically and 
graded as minimal (+), mild (++), moderate (+++), marked (++++) or severe 
(+++++). 
 
3. Results 
3.1. M148R and M149R are two ANK repeats and F-box containing proteins 
Depending on the software used for protein analysis, up to 10 ANK repeats can be 
identified in M148R, and up to 9 in M149R (Fig. 1). The newly established 
PRANC (Pox protein Repeats of Ankyrin C-terminal) domain, belonging to the F-
box motif family, is present in both proteins. 
 
3.2. M148R and M149R are expressed sequentially during the infection 
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Manual analysis, according to published consensus promoter and terminator 
sequences, revealed sequences consistent with a late transcription of M148R. No 
sequence clearly corresponding to early or late promoter was found upstream of 
the ATG of M149R. 
RT-PCR analysis of total RNA purified from wild-type MYXV-infected cells 
demonstrated that the M148R transcript was weakly detectable as early as 2 h p.i.. 
The expression of M148R increased up to 16 h p.i. and is totally inhibited in the 
presence of AraC (Fig. 2 upper panel).  
The M149R transcript was detectable as early as 2 h p.i., and could still be 
detected at 16 h p.i. (Fig. 2 middle panel). However, the level of detected 
transcript was noticeably lower following the treatment with AraC, as opposed to 
what was observed with MNF (M150R), control of early gene expression (Fig. 2 
lower panel). Since M148R, M149R and MNF are organized in a cluster of genes, 
temporally expressed in the reverse sense of their location, one could influence 
the expression of the others. Therefore, RT-PCR analysis of expression of M148R 
and M149R in T1MNF-infected RK13 cells was performed. MNF deletion 
affects neither M148R nor M149R transcription (data not shown). Likewise, 
deletion of M149R does not affect M148R transcription.  
 
3.3. M148R and M149R have different subcellular localizations 
To determine the subcellular localization of each protein, plasmids expressing a 
GFP-protein fusion (with M148R or M149R fused downstream of the GFP, under 
CMV promoter) were used to transfect BGMK cells. Cells were examined by 
confocal microscopy at 24 h p.t.. As shown in Figure 3Aa, GFP-M148R fusion is 
located in both the cytoplasm and nucleus. The nuclear fraction of M148R shows 
a nucleolar pattern, as confirmed by colocalization (Fig. 3Ac, yellow merge 
staining) with B23 (nucleophosmin, Fig. 3Ab, red staining), a major 
multifunctional nucleolar phosphoprotein. A punctuate pattern with a uniform 
distribution in the cytoplasm was observed with the GFP-M149R fusion (Fig. 
3Ad). It was not possible to show any colocalization with the endoplasmic 
reticulum, early endosomes, or lysosome (data not shown). Typical diffuse 
(cytoplasmic and nuclear) green pattern was observed with the control 
transfection with a GFP expressing plasmid (data not shown). 
The same patterns were observed in an infectious context, with GFP-fusions 
expressed under P7.5 poxviral promoter (Fig. 3B). Absence of green staining in 
BGMK transfected with pBS-7.5GFPM148R or pBS-7.5GFPM149R without 
infectious context confirmed that fusion expression under the P7.5 promoter 
requires MYXV infection (data not shown). 
 
3.4. M148R and M149R are not essential for replication in classical MYXV 
permissive cells 
The role of M148R and M149R in the replication of MYXV was evaluated by 
engineering mutant viruses deleted in either M148R (MYXV-M148R), or 
M149R (MYXV-M149R), or both (MYXV-M148RM149R). The capacity of 
replication of mutant viruses in cultured cell lines (RK13 and BGMK) and 
primary cells (PBMC) was tested. Experiments showed that neither deletion of 
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M148R, nor M149R, nor both, induced modification in virus replication in RK13, 
BGMK, or PBMC (Fig. 4A). In order to examine mutant viruses spread in 
cultured cells, multi-step experiments on RK13 and BGMK cells were performed. 
No defects in the ability of mutant viruses to spread in these cells were observed 
(Fig. 4B).  
 
3.5. M148R and M149R are new MYXV virulence factors in European 
rabbits 
To evaluate the role of M148R and M149R in the pathobiology of MYXV, 
European rabbits were inoculated intradermally with either wild type MYXV 
strain T1, MYXV-M148R, MYXV-M149R, MYXV-M148RM149R, or 
MYXV-rev (control of phenotype specificity). The clinical course of infection 
was monitored daily for 21 days. Data are summarized in Table I. Rabbits 
infected with the T1 strain developed typical clinical myxomatosis, characterized 
by the development at day 4 p.i. of a large red and raised primary skin lesion at 
the inoculation site. At day 8 p.i., secondary lesions appeared on ears, eyelids, 
nose, back and subsequentially over the entire body. Conjunctivas inflammation 
and initially serous, later mucopurulent (day 10 p.i.) discharge from the nose and 
eyes followed, accompanied by respiratory distress (day 12 p.i.). Rabbits died 
within 2 weeks due to bacterial infection of the respiratory tract. The same clinical 
course of infection was observed with MYXV-rev infected rabbits. 
Clinical observations revealed that infection with the MYXV-M148R, MYXV-
M149R and MYXV-M148RM149R mutants is clearly attenuated compared 
to wild type virus infection. The MYXV-M148R infected group showed a delay 
of 3 days in the onset of clinical signs, with a mortality rate of 40%. They suffered 
from only light infections of conjunctivas and respiratory tract. MYXV-M149R 
induced a delay of 4 days on the onset of secondary lesions, which were less 
numerous and restricted to the face area. All infected animals recovered. Finally, 
all rabbits infected with the MYXV-M148RM149R showed few clinical signs, 
except for secondary lesions which appeared earlier (day 6 p.i.) than usual, were 
smaller and more numerous, and finally resorbed rapidly. All rabbits recovered. 
 
3.6. Histological analysis of lesions from wild type and mutant MYXV 
Detailed histological examination of tissue material from both the primary (ear) 
and secondary (parotid lymph node) infection sites was carried out at various 
times during the course of infection. The results of the complete analysis are 
summarized in Table II. 
At day 5 p.i., the injection sites of wild-type MYXV and mutant viruses 
demonstrated similar microscopic lesions, i.e. perivascular dermatitis with focal 
edema, interstitial mucinosis and inflammatory infiltrates mainly composed of 
heterophils. In the parotid lymph node, both mutant and wild-type viruses induced 
a lymphadenitis with lymphoid hyperplasia, focal histiocytosis and moderate 
infiltration by heterophils. 
At day 8 p.i., the injection sites of wild-type MYXV, MYXV-M148R and 
MYXV-M148RM149R showed a difference in the nature of inflammatory 
infiltrates in the myxomas. With wild-type MYXV (as with the MYXV-M149R, 
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to a lesser extent), heterophils still composed the main cellular population. By 
contrast, for the lesions associated with the MYXV-M148R and MYXV-
M148RM149R, sequential inflammatory cellular reactions progressed more 
rapidly, as attested by the presence of infiltrates with a majority of mononuclear 
cells (histiocytes and lymphocytes). In the parotid lymph node, a lymphadenitis 
with lymphoid hyperplasia and focal histiocytosis was observed for all viruses. As 
for the primary site, infiltration by heterophils was more pronounced for wild-type 
MYXV and MYXV-M149R than for MYXV-M148R and MYXV-
M148RM149R. The presence of activated fibroblasts with interstitial 
mucinosis was greater with wild-type MYXV than with all other viruses. 
At day 13 p.i., the injection sites of wild-type MYXV, MYXV-M148R and 
MYXV-M148RM149R still showed a difference in the nature of inflammatory 
infiltrates in the myxomas. With wild-type MYXV as with MYXV-M149R, the 
proportions of heterophils and mononuclear cells (histiocytes, lymphocytes, and 
plasmocytes) tended to become counterbalanced. For the lesions associated with 
MYXV-M148R and MYXV-M148RM149R, mononuclear cells were 
markedly predominant. The number of activated fibroblasts and the amount of 
interstitial mucinosis were greater with wild-type MYXV than with all other 
viruses. In the parotid lymph node, both mutant and wild-type viruses showed a 
lymphadenitis with lymphoid hyperplasia and focal histiocytosis. 
From these observations, we can conclude that the inflammatory reaction is more 
rapidly resolved for MYXV-M148R and MYXV-M148RM149R (at day 8 
p.i., mononuclear cells were predominant) than for wild-type MYXV and MYXV-
M149R. Another difference was the very high level of cellular density of 
activated fibroblasts and interstitial mucinosis in lesions induced by wild-type 
MYXV at day 13 p.i. in comparison with lesions induced by other viruses. 
 
4. Discussion 
This study is the first characterization of M148R and M149R, two of the four 
ANK repeat proteins encoded by MYXV. We demonstrate that M148R and 
M149R are virulence factors of MYXV. 
Our experiments provide new data on M148R and M149R expression. They were 
first described as early genes coding for cytoplasmic proteins with 9 ANK repeats 
and 4 putative transmembrane regions and with 8 ANK repeats, respectively [5]. 
We show that M148R is expressed as a late gene and that up to 10 ANK repeats 
can be identified in the protein. We also show that M149R is expressed earlier 
than M148R, is partially inhibited by AraC and that up to 9 ANK repeats can be 
identified in the protein. The observed decrease in M149R expression level, due to 
AraC treatment, suggests that M149R expression level partially relies on viral 
DNA replication. No sequence clearly corresponding to early or late promoters 
was found upstream of the ATG of M149R. However, the GG dinucleotide can be 
found immediately after a TAATAT motif (a part of the ATG), compatible with 
an intermediate signal. On the contrary, an early transcription termination signal is 
present two nucleotides upstream of the stop codon. Interestingly, the M148R and 
M149R form, with MNF, a cluster of genes coding for ANK repeat proteins, 
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temporally expressed in the reverse sense of their location, without a 
transcriptional effect from the ones on the others. 
M148R and M149R were predicted to be cytoplasmic proteins [5]. This was 
confirmed for M149R. In contrast we show that M148R is located in both the 
cytoplasm and nucleolus, with or without a viral context. This suggests that no 
viral cofactor is required to address M148R to the nucleolus. Though no classical 
nuclear localization signal (NLS) was identified in M148R, it has been shown that 
ANK repeats can be used as a non typical NLS [24]. This has been verified for 
MNF since deletion of its eighth ANK repeat prevents MNF translocation to the 
nucleus [6]. This may also be the case for M148R.  
As initial studies on poxviral ANK repeat proteins, such as Vaccinia virus K1L [3, 
22] and M-T5 [18], have demonstrated they were involved in cell tropism or host 
range functions, the role of M148R and M149R in the replication of MYXV was 
evaluated. We show that deletion of M148R, M149R, or both, does not induce 
modification in virus replication in rabbit cells (fibroblast cell lines or PBMC) or 
in BGMK cells. Thus M148R and M149R do not seem to be implicated in either 
cell tropism or host range functions, based upon the cell lines examined. 
However, we show that single deletion of M148R or M149R induces a delay in 
the onset of blepharitis and respiratory infections, an increase of survival time and 
a dramatic decrease in mortality rate. Moreover, MYXV-M148RM149R 
infected rabbits expressed only moderate blepharitis, no signs of respiratory 
infection and totally recovered. Since there are no significant differences between 
virus replication in rabbit lymphocytes, we can conclude that the observed delay 
in clinical sign onset and the attenuated phenotype cannot be explained by 
impairment of virus diffusion after intradermal infection. MYXV-M149R 
induced few secondary lesions that appeared later than with the other viruses and 
were located on the face only. Surprisingly, MYXV-M148RM149R infected 
rabbits had earlier, smaller and more numerous secondary lesions that resorbed 
faster than rabbits infected with other viruses, including the wild type one. 
Therefore, clinical signs observed after infection with MYXV-M148RM149R 
seem to be different from the simple addition effect of attenuated phenotypes 
induced by each single deleted virus. This suggests that M148R and M149R may 
act in synergy. 
Histological analysis of the primary myxoma (inoculation site) and parotid lymph 
node showed that deletion of the M148R gene allowed a quicker resolution of the 
inflammation. Therefore, like MNF, M148R is located in the cell nucleus and 
seems to play a role in the subverting of inflammatory response by MYXV. 
However, deletion of MNF induces more drastic attenuation than M148R deletion 
and they do not seem to be located in the same subnuclear compartment [6]. 
Indeed M148R is located in part in the nucleolus of infected cells. For many 
years, the exclusive function of the nucleolus was thought to be ribosomal rRNA 
synthesis and ribosome biogenesis. However, the nucleolus has been recently 
implicated in many aspects of cell biology that include functions such as gene 
silencing, senescence and cell cycle regulation [19-21]. Numerous viruses encode 
proteins that interfere with the nucleolus, such as EBNA5 of the Epstein Barr 
virus [30], ICP27 of the Herpes simplex virus [16] or Rev and Tat of HIV-1 [8, 
 11
10, 26]. However, reasons for targeting host-cell nucleoli and mechanisms used to 
subvert nucleolar functions are usually speculative. It may favor viral 
transcription, translation or alter the cell cycle in order to promote virus 
replication. 
If ANK repeat proteins are involved in a large set of functions, the conserved role 
of the ANK motif is to be a mediator of specific protein-protein interactions. As 
the majority of ANK repeats poxviral proteins, M148R and M149R have an F-box 
sequence at the C-terminus. Both motifs are rare among viruses but are abundant 
in poxviruses [2, 17]. Moreover, poxviral F-box motifs are not typical compared 
to those found in eukaryotes for which F-box motifs are located at the N-terminus 
of the protein and are associated with WD repeats and leucine-rich repeats as 
classical protein-protein interaction domain [12]. F-box proteins are involved in 
ubiquitin-dependent proteolysis in cell cycle regulation and signal transduction. 
They are recognition subunits of ubiquitin ligase complexes where the F-box 
domain binds to ubiquitin ligase and where protein-protein interaction domain 
binds the substrate protein [13]. Based on these observations, Mercer et al. 
proposed that poxviral ANK-F-box proteins work as described, using ANK 
repeats to interact with the target protein and to direct its ubiquitination [17]. It 
was confirmed for the VACV 68k protein [28] and for five Orf virus proteins 
[27]. All these ANK-F-box poxviral proteins co-precipitated with Skp1 and 
Cullin-1, two components of SCF1 ubiquitin ligase complex. All these proteins 
have different localizations such as cytoplasmic, nuclear, perinucleolar, but none 
has been shown to be nucleolar as is M148R. We attempted to co-precipitate 
Cullin-1 in BGMK cells transfected with the GFP fusion of M148R and M149R, 
under CMV promoter. We succeeded in precipitating the fusion proteins, but 
failed to demonstrate any interaction with neither Cullin-1 nor Skp1 (data not 
shown). These experiments are not conclusive enough to totally exclude an 
interaction between these proteins. New experiments should be done in conditions 
of infection, in primate and rabbit cells. Moreover, possible interactions with other 
partners known to interact with some ANK-F-box poxviral proteins such as 
proteins of Akt pathway [33] or mainly NFB signaling pathway, as is the case 
for K1L [25] and MNF [6], need to be explored. 
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Figure Legends 
Figure 1. Functional domains of M148R and M149R Myxoma virus proteins. (A) 
Functional domains of M148R and M149R proteins found by 3 online  
software: Pfam [11], REP[1] and SMART [14]. “trunc” (truncated) indicates that 
only the second half of the repeat was identified. (B) Schematic representation of 
M148R and M149R proteins. Gray boxes: ANK repeat; hatched: PRANC (Pox 
protein Repeats of Ankyrin C-terminal) domain. 
 
Figure 2. Expression of M148R and M149R mRNA in cell culture. RK13 cells 
were infected with wild type MYXV. At different times p.i., mRNA were 
extracted, subjected to reverse transcription using oligodT primers, following 
which, PCR was performed using specific primers for M148R (A), M149R (B), or 
M150R (C). Lane +, positive control, i.e PCR on T1 DNA; lane -, negative 
control, i.e PCR without template; lanes T0 through T16, cells infected with wild-
type MYXV for 0, 2, 4, 8, 12, or 16 h, respectively; lane n.i., mock-infected cells; 
lane AraC, cells infected with wild-type MYXV for 16 h and incubated with AraC 
at the time of infection. T0 corresponds to RNA extractions performed after 1h of 
virus adsorption. 
 
Figure 3. Cellular localization of M148R and M149R. (A) BGMK cells grown on 
coverslips were transfected with pCMV-GFPM148R (a, b, c) or pCMV-
GFPM149R (d, e, f). Cells were fixed at 24 h p.t., permeabilized, stained with 
anti-B23 antibody (red staining) and TO-PRO-3 iodide to detect nuclei (blue 
staining), and analyzed by confocal microscopy with a 60× objective. 
Multistaining experiments were performed using the sequential mode. (B) BGMK 
cells grown on coverslips were pBS-P7.5GFPM148R (a, b, c) or pBS-
P7.5GFPM149R (d, e, f) transfected, with prior 2 h infection with the MYXV 
deleted for the corresponding gene. At 24 h p.t., cells were fixed, permeabilized, 
stained with anti-MYXV serum (red staining) and analyzed by confocal 
microscopy as previously indicated. 
 
Figure 4. Growth kinetics of wild-type and mutant viruses. (A) To evaluate 
viruses in vitro replication, cell lines (RK13 and BGMK) and primary cells 
(PBMC) were respectively infected at m.o.i. 4 and m.o.i. 1, with wild-type 
MYXV (thin solid line ()), MYXV-M148R (bold dashed line ()), MYXV-
M149R (thin dashed line ()) or MYXV-M148RM149R (bold solid line 
(×)). Virus titers were determined at different times p.i. on RK13 cells. Results are 
shown as means ± SEM (triplicate). (B) To examine virus spread, cells were 
infected at a low m.o.i. (m.o.i. =0,01). Virus titers were determined at different 
times p.i. as indicated above. Results are shown as means ± SEM (duplicate).  
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Figure 1 
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Figure 2
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Figure 3  
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Figure 4  
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